メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
腫瘍医学研究センター
研究推進本部
総合医科学研究部門
概要
フィンガープリント
ネットワーク
プロファイル
(8)
研究成果
(28)
フィンガープリント
腫瘍医学研究センターが活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
3C-like Protease (3CLpro)
44%
ACE2 Inhibition
14%
Alpha Variant
8%
Authentic Virus
14%
Beta Variant
8%
Between-sex Differences
7%
Biological Observations
14%
Biological Significance
7%
BNT162b2 Vaccine
22%
Breakthrough Infection
8%
Cancer Cells
44%
Cancer Invasion
7%
Cancer Metastasis
7%
Cancer Stem Cells
88%
CD177
44%
CD44v
33%
Cell Adhesion
7%
Cell Surface Markers
11%
Cellular Phenotype
7%
Charles Darwin
14%
Chemotherapy
7%
Cluster of Differentiation 44 (CD44)
44%
Contact History
6%
COVID-19 Diagnosis
5%
COVID-19 Patients
44%
COVID-19 Risk
5%
Cystine
11%
Cystine Transporter
11%
D614G
8%
Delta Variant
17%
Diagnostic Applications
44%
Difference Response
7%
Epigenetic Modification
7%
Epithelial Tumor
11%
Epithelial-mesenchymal Transition
44%
Evolution Mechanism
14%
Female Presence
44%
Function-based
11%
Gamma Variant
8%
Gene mutation
7%
Glutamate
11%
GSH Synthesis
11%
Heterogeneous Cell Population
7%
High-fidelity DNA Polymerase
7%
Hospital Infection Control
6%
Hydrogen-deuterium Exchange Mass Spectrometry
5%
In Cancer
44%
Individual Survival
14%
Indolent Disease
7%
Institutional Level
6%
Intracellular Antioxidants
11%
Kappa Variant
8%
Large Variance
5%
Lymphocyte Doubling Time
7%
Malignant Characteristics
7%
Migratory Behavior
7%
Mild COVID-19
44%
Mild Patients
29%
Model Identification
44%
N Protein
14%
Non-cancer
7%
Non-hazardous
8%
Novel Functions
11%
Pandemic Control
14%
PCR Test
14%
PF-07321332
5%
PI-IBS
44%
Pluripotency
7%
Post-vaccination Antibodies
44%
Pre-pandemic
14%
Prognostic Correlation
6%
Protease Enzyme
5%
Reactive Oxygen Species
11%
Reactive Oxygen Species Level
11%
Redox Regulation
44%
Reduced Glutathione
11%
Reg3γ
6%
Response Reaction
7%
S1 Domain
14%
SARS-CoV-2 Pneumonia
44%
SARS-CoV-2 Spike Protein
7%
SARS-CoV-2 Strains
5%
SARS-CoV-2 Vaccination
44%
SARS-CoV-2 Variants
8%
Self-renewal
7%
Species Evolution
29%
Stem Cell Genes
7%
Structural Perturbation
5%
Tumor
7%
Tumor Cells
7%
Tumor Formation
7%
Tumor Invasion
44%
Tumor Metastasis
44%
Tumor Microenvironment
11%
Tumor Tissue
7%
University Staff
44%
Vaccine Titer
7%
Variant Forms
11%
Variants of Concern
44%
Wuhan
26%
Medicine and Dentistry
Antioxidant
11%
Bronchopneumonia
22%
Cancer Cell
44%
Cancer Stem Cell
88%
Carcinogen
14%
Carcinogenesis
22%
Cell Adhesion
7%
Cell Adhesion Assay
8%
Cell Population
7%
Cell Surface Marker
11%
Constipation
8%
Coronavirinae
24%
COVID-19
44%
COVID-19 Vaccination
44%
Cystine
22%
Diarrhea
20%
Diffuse Alveolar Damage
22%
Disease
24%
DNA-directed DNA Polymerase
7%
Epithelioma
11%
Gastrointestinal Distress
44%
Gene Expression
22%
Gene Expression Profiling
44%
Gene Mutation
7%
Genomic RNA
6%
Glandular Stomach
7%
Glutamic Acid
11%
Glutathione
11%
Helicobacter Infection
37%
Helicobacter Pylori
44%
High Salt Diet
44%
Histopathology
22%
Hydrogen/Deuterium Exchange Mass Spectrometry
5%
Infection
44%
Irritable Bowel Syndrome
44%
Isoprotein
8%
Mesenchymal-Epithelial Transition
44%
Metastatic Carcinoma
44%
Microarray Analysis
7%
Mixed Infection
44%
Multivariate Analysis
7%
Nausea
12%
Neoplasm
14%
Nitrosourea
7%
Observational Study
44%
Oligonucleotide
7%
Overall Survival
7%
Pathogen
22%
Pneumococcal Infection
22%
Prognostic Factor
44%
Pulmonary Pathology
44%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Rapid Test
31%
Reactive Oxygen Species
22%
Respiratory Failure
22%
Salt Intake
7%
Severe Acute Respiratory Syndrome Coronavirus 2
48%
Solid Malignant Neoplasm
7%
Stomach Cancer
44%
Stomach Carcinogenesis
14%
Stomach Tumor
44%
Streptococcus Pneumoniae
44%
Symptom
44%
Tumor Cell
7%
Tumor Invasion
44%
Tumor Microenvironment
11%
Tumor Model
44%
Immunology and Microbiology
Antibody Blood Level
22%
Antibody Response
19%
Antibody Titer
44%
Antigen Expression
44%
Blood Group A Antigen
7%
Breakthrough Infection
6%
Cancer Stem Cell
44%
CD44
88%
Cell Proliferation
7%
Cell Surface Marker
11%
COVID-19
88%
Cycline
44%
DNA Polymerase
7%
Genome Sequencing
22%
Haplotype
22%
Humoral Immunity
50%
Hydrogen/Deuterium Exchange Mass Spectrometry
14%
Leukemia Cell
7%
Lymphocyte
7%
Lymphocytopenia
11%
Monospecific Antibody
22%
Neutralization
11%
Neutralizing Antibody
44%
Polymerase Chain Reaction
11%
Procalcitonin
11%
Prostate
44%
Receptor Binding
17%
Serology
11%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Sex Difference
6%
Spike
28%
Titer
34%
Vaccination Policy
44%
Vaccine Efficacy
25%
Virus Genome
22%
Virus Neutralization
11%
Western Blot
7%
Whole Genome Sequencing
44%